BNCT治療薬剤 3-BAMPA(3-ボロノ-α-メチルフェニルアラニン)の開発と臨床応用

• Project/Area Number: 25K10902
• Research Category: Grant-in-Aid for Scientific Research (C)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 52040:Radiological sciences-related
• Research Institution: Shonan Kamakura General Hospital, Medical Corporation Tokushukai (Center for Clinical and
• Principal Investigator: 冨吉 勝美 医療法人徳洲会湘南鎌倉総合病院(臨床研究センター), 湘南先端医学研究所 放射線医学研究部, 主任研究員 (60188802)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000); Fiscal Year 2027: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000); Fiscal Year 2026: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000); Fiscal Year 2025: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)